These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 22946104)

  • 1. Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1.
    Chou CW; Wang CC; Wu CP; Lin YJ; Lee YC; Cheng YW; Hsieh CH
    Neuro Oncol; 2012 Oct; 14(10):1227-38. PubMed ID: 22946104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NADPH oxidase subunit 4-mediated reactive oxygen species contribute to cycling hypoxia-promoted tumor progression in glioblastoma multiforme.
    Hsieh CH; Shyu WC; Chiang CY; Kuo JW; Shen WC; Liu RS
    PLoS One; 2011; 6(9):e23945. PubMed ID: 21935366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NADPH oxidase subunit 4 mediates cycling hypoxia-promoted radiation resistance in glioblastoma multiforme.
    Hsieh CH; Wu CP; Lee HT; Liang JA; Yu CY; Lin YJ
    Free Radic Biol Med; 2012 Aug; 53(4):649-58. PubMed ID: 22713363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cycling hypoxia induces chemoresistance through the activation of reactive oxygen species-mediated B-cell lymphoma extra-long pathway in glioblastoma multiforme.
    Chen WL; Wang CC; Lin YJ; Wu CP; Hsieh CH
    J Transl Med; 2015 Dec; 13():389. PubMed ID: 26711814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme.
    Hsieh CH; Lin YJ; Wu CP; Lee HT; Shyu WC; Wang CC
    Clin Cancer Res; 2015 Jan; 21(2):460-70. PubMed ID: 25370472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cycling hypoxia increases U87 glioma cell radioresistance via ROS induced higher and long-term HIF-1 signal transduction activity.
    Hsieh CH; Lee CH; Liang JA; Yu CY; Shyu WC
    Oncol Rep; 2010 Dec; 24(6):1629-36. PubMed ID: 21042761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-κB signaling pathway.
    Jin P; Shin SH; Chun YS; Shin HW; Shin YJ; Lee Y; Kim D; Nam DH; Park JW
    Oncogene; 2018 Jun; 37(23):3070-3087. PubMed ID: 29535421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of hypoxia-inducible factor-1alpha (HIF-1alpha) as an intrinsic marker of tumor hypoxia in U87 MG human glioblastoma: in vitro and xenograft studies.
    Vordermark D; Brown JM
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1184-93. PubMed ID: 12829158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HIF‑1α/miR‑224‑3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia‑induced protective autophagy in glioblastoma and astrocytoma.
    Huang S; Qi P; Zhang T; Li F; He X
    Oncol Rep; 2019 Mar; 41(3):1759-1768. PubMed ID: 30569180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of Nrf2 suppresses glioblastoma angiogenesis by inhibiting hypoxia-induced activation of HIF-1α.
    Ji X; Wang H; Zhu J; Zhu L; Pan H; Li W; Zhou Y; Cong Z; Yan F; Chen S
    Int J Cancer; 2014 Aug; 135(3):574-84. PubMed ID: 24374745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/β-catenin pathway.
    Riganti C; Salaroglio IC; Caldera V; Campia I; Kopecka J; Mellai M; Annovazzi L; Bosia A; Ghigo D; Schiffer D
    Neuro Oncol; 2013 Nov; 15(11):1502-17. PubMed ID: 23897632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells.
    Ahmed EM; Bandopadhyay G; Coyle B; Grabowska A
    Cell Oncol (Dordr); 2018 Jun; 41(3):319-328. PubMed ID: 29492900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.
    Yin J; Ge X; Shi Z; Yu C; Lu C; Wei Y; Zeng A; Wang X; Yan W; Zhang J; You Y
    Theranostics; 2021; 11(4):1763-1779. PubMed ID: 33408780
    [No Abstract]   [Full Text] [Related]  

  • 14. An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells.
    Lau CK; Yang ZF; Ho DW; Ng MN; Yeoh GC; Poon RT; Fan ST
    Clin Cancer Res; 2009 May; 15(10):3462-71. PubMed ID: 19447872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis.
    Ge X; Pan MH; Wang L; Li W; Jiang C; He J; Abouzid K; Liu LZ; Shi Z; Jiang BH
    Cell Death Dis; 2018 Nov; 9(11):1128. PubMed ID: 30425242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment.
    Nigim F; Cavanaugh J; Patel AP; Curry WT; Esaki S; Kasper EM; Chi AS; Louis DN; Martuza RL; Rabkin SD; Wakimoto H
    J Neuropathol Exp Neurol; 2015 Jul; 74(7):710-22. PubMed ID: 26083570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition.
    Rapisarda A; Hollingshead M; Uranchimeg B; Bonomi CA; Borgel SD; Carter JP; Gehrs B; Raffeld M; Kinders RJ; Parchment R; Anver MR; Shoemaker RH; Melillo G
    Mol Cancer Ther; 2009 Jul; 8(7):1867-77. PubMed ID: 19584228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factor 1alpha and vascular endothelial growth factor in Glioblastoma Multiforme: a systematic review going beyond pathologic implications.
    Vageli DP; Doukas PG; Goupou K; Benos AD; Astara K; Zacharouli K; Sotiriou S; Ioannou M
    Oncol Res; 2024; 32(8):1239-1256. PubMed ID: 39055895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia.
    Mao XG; Xue XY; Wang L; Zhang X; Yan M; Tu YY; Lin W; Jiang XF; Ren HG; Zhang W; Song SJ
    Neuro Oncol; 2013 Jul; 15(7):865-79. PubMed ID: 23645533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of hypoxia-inducible factor-1 alpha in the upregulation of P-glycoprotein in refractory epilepsy.
    Wang G; Xie G; Han L; Wang D; Du F; Kong X; Su G
    Neuroreport; 2019 Dec; 30(17):1191-1196. PubMed ID: 31634239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.